{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:45:42Z","timestamp":1792111542658,"version":"4.4.0"},"reference-count":80,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100005292","name":"Evergreen Award, Brigham and Women\u2019s Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Corticotroph adenomas (CA) include functioning tumors causing Cushing disease (CD) and silent corticotroph adenomas (SCA), which differ markedly in size, clinical presentation, and aggressiveness. The molecular basis for these differences remains incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To characterize genomic and transcriptomic alterations underlying the divergent clinical behavior of CD and SCA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty-eight tumors from 34 patients underwent whole-exome sequencing, copy-number variation (CNV) analysis, and mRNA sequencing. Molecular findings were integrated with clinical, radiological, and pathological data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>USP8\/USP48 mutations were present in 10 of 21 CD tumors (48%) and were associated with low CNV levels, minimal invasion, and favorable post-operative remission. In contrast, five of 13 SCAs harbored TP53\/ATRX\/DAXX mutations, all had markedly elevated CNV, and aggressive clinical features. Transcriptomic analysis identified an ATRX-FAM138A mRNA fusion, resulting in loss of ATRX expression in an aggressive tumor. Unsupervised transcriptome analyses defined four clusters. All USP8\/USP48-mutant CD clustered together had low CNV and low recurrence rates. Cluster 2 consisted of a mixture of CD and SCA, with intermediate CNV and nonaggressive behavior. Cluster 3 included USP8-wildtype CD with heterogeneous yet generally nonaggressive courses. Cluster 4 represented high-CNV tumors enriched for TP53\/ATRX\/DAXX alterations, with the highest rates of radiological invasion, persistent disease, and recurrence or progression. Across the cohort, higher CNV was significantly associated with parameters of aggressiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CA comprise distinct molecular subtypes. USP8\/USP48-mutant CD represents a low-CNV, low-risk group, whereas tumors harboring TP53\/ATRX\/DAXX mutations exhibit high CNV and aggressive clinical behavior. CNV and mutation profiling may assist in postoperative risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgag229","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:50:09Z","timestamp":1781092209000},"page":"3062-3074","source":"Crossref","is-referenced-by-count":0,"title":["Distinct genetic alterations drive Cushing disease vs silent corticotroph adenomas"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3078-5200","authenticated-orcid":false,"given":"Ticiana","family":"Paes","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Mass General Brigham, Department of Medicine, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]},{"name":"Department of Internal Medicine, Roger Williams Medical Center , Providence, RI 02908 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Mass General Brigham, Department of Medicine, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]},{"name":"Department of Neurosurgery and National Center for Neurological Disorders, Huashan Hospital, Shanghai Medical College, Fudan University , Shanghai 200040 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarice O","family":"Borges","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Mass General Brigham, Department of Medicine, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipika R","family":"Mohan","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism & Lipid Research, Department of Medicine, Washington University School of Medicine , St. Louis, MO 63108 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Vaz","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Mass General Brigham, Department of Medicine, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz S","family":"Soares","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Mass General Brigham, Department of Medicine, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]},{"name":"Division of Endocrinology, Department of Medicine, Federal University of Minas Gerais , Minas Gerais 30130-100 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rona S","family":"Carroll","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Mass General Brigham, Department of Medicine, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8237-0704","authenticated-orcid":false,"given":"Ursula B","family":"Kaiser","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Mass General Brigham, Department of Medicine, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mass General Brigham, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenya Linda","family":"Bi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mass General Brigham, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7054-8624","authenticated-orcid":false,"given":"David","family":"Meredith","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women's Hospital and Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio M","family":"Lerario","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan , Ann Arbor, MI 48106 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5505-0852","authenticated-orcid":false,"given":"Ana Paula","family":"Abreu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Mass General Brigham, Department of Medicine, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"issue":"10","key":"2026101520035944200_dgag229-B1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJMra1810772","article-title":"Pituitary-tumor endocrinopathies","volume":"382","author":"Melmed","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"2026101520035944200_dgag229-B2","doi-asserted-by":"crossref","first-page":"104091","DOI":"10.1016\/j.lpm.2021.104091","article-title":"Cushing's disease","volume":"50","author":"Ferriere","year":"2021","journal-title":"Presse Med"},{"issue":"2","key":"2026101520035944200_dgag229-B3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11102-014-0624-3","article-title":"Silent corticotroph adenomas","volume":"18","author":"Cooper","year":"2015","journal-title":"Pituitary"},{"issue":"9","key":"2026101520035944200_dgag229-B4","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.3390\/ijms23094861","article-title":"The genomic landscape of corticotroph tumors: from silent adenomas to ACTH-secreting carcinomas","volume":"23","author":"Andonegui-Elguera","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2026101520035944200_dgag229-B5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/ejendo\/lvaf086","article-title":"Non-recurrent mutations and copy number changes predominate pituitary adenoma genomes","volume":"192","author":"Mohan","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026101520035944200_dgag229-B6","doi-asserted-by":"crossref","first-page":"a028373","DOI":"10.1101\/cshperspect.a028373","article-title":"The role of aneuploidy in cancer evolution","volume":"7","author":"Sansregret","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"2026101520035944200_dgag229-B7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00401-024-02736-8","article-title":"Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors","volume":"147","author":"Lin","year":"2024","journal-title":"Acta Neuropathol"},{"issue":"10","key":"2026101520035944200_dgag229-B8","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4158\/EP-2018-0111","article-title":"Pathogenesis of Cushing disease: an update on the genetics of corticotropinomas","volume":"24","author":"Albani","year":"2018","journal-title":"Endocr Pract"},{"issue":"3","key":"2026101520035944200_dgag229-B9","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1210\/clinem\/dgaa853","article-title":"USP8 and TP53 drivers are associated with CNV in a corticotroph adenoma cohort enriched for aggressive tumors","volume":"106","author":"Uzilov","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026101520035944200_dgag229-B10","doi-asserted-by":"crossref","first-page":"1302667","DOI":"10.3389\/fendo.2024.1302667","article-title":"Relevance of mutations in protein deubiquitinases genes and","volume":"15","author":"P\u0119kul","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"2026101520035944200_dgag229-B11","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/neuonc\/noz109","article-title":"Driver mutations in USP8 wild-type Cushing's disease","volume":"21","author":"Sbiera","year":"2019","journal-title":"Neuro Oncol"},{"issue":"3","key":"2026101520035944200_dgag229-B12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/cr.2015.20","article-title":"Recurrent gain-of-function USP8 mutations in Cushing's disease","volume":"25","author":"Ma","year":"2015","journal-title":"Cell Res"},{"issue":"11","key":"2026101520035944200_dgag229-B13","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/cr.2016.114","article-title":"The genome-wide mutational landscape of pituitary adenomas","volume":"26","author":"Song","year":"2016","journal-title":"Cell Res"},{"issue":"1","key":"2026101520035944200_dgag229-B14","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1038\/s41467-018-05275-5","article-title":"Identification of recurrent USP48 and BRAF mutations in Cushing's disease","volume":"9","author":"Chen","year":"2018","journal-title":"Nat Commun"},{"issue":"5","key":"2026101520035944200_dgag229-B15","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1210\/jc.2018-02164","article-title":"Large genomic aberrations in corticotropinomas are associated with greater aggressiveness","volume":"104","author":"Tatsi","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026101520035944200_dgag229-B16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s40478-020-01067-5","article-title":"Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis","volume":"8","author":"Lasolle","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2026101520035944200_dgag229-B17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","article-title":"Pangenomic classification of pituitary neuroendocrine tumors","volume":"37","author":"Neou","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"2026101520035944200_dgag229-B18","doi-asserted-by":"crossref","first-page":"19373","DOI":"10.1038\/s41598-020-76555-8","article-title":"Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors","volume":"10","author":"Taniguchi-Ponciano","year":"2020","journal-title":"Sci Rep"},{"issue":"5","key":"2026101520035944200_dgag229-B19","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s11102-022-01253-9","article-title":"Genetics of Cushing's disease: from the lab to clinical practice","volume":"25","author":"Theodoropoulou","year":"2022","journal-title":"Pituitary"},{"issue":"6","key":"2026101520035944200_dgag229-B20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1530\/EJE-19-0194","article-title":"USP8 mutations in corticotroph adenomas determine a distinct gene expression profile irrespective of functional tumour status","volume":"181","author":"Bujko","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2026101520035944200_dgag229-B21","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41422-022-00736-5","article-title":"Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors","volume":"32","author":"Zhang","year":"2022","journal-title":"Cell Res"},{"issue":"8","key":"2026101520035944200_dgag229-B22","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/neuonc\/noab044","article-title":"DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features","volume":"23","author":"Mosella","year":"2021","journal-title":"Neuro Oncol"},{"issue":"4","key":"2026101520035944200_dgag229-B23","doi-asserted-by":"crossref","first-page":"e96178","DOI":"10.1371\/journal.pone.0096178","article-title":"A pilot genome-scale profiling of DNA methylation in sporadic pituitary macroadenomas: association with tumor invasion and histopathological subtype","volume":"9","author":"Ling","year":"2014","journal-title":"PLoS One"},{"issue":"17","key":"2026101520035944200_dgag229-B24","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1158\/1078-0432.CCR-17-2206","article-title":"The epigenomic landscape of pituitary adenomas reveals specific alterations and differentiates among acromegaly, Cushing's disease and endocrine-inactive subtypes","volume":"24","author":"Salomon","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2026101520035944200_dgag229-B25","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1210\/clinem\/dgac703","article-title":"Integrating methylome and transcriptome signatures expands the molecular classification of the pituitary tumors","volume":"108","author":"Silva-J\u00fanior","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026101520035944200_dgag229-B26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2026101520035944200_dgag229-B27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-09-0627","article-title":"The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline: commentary from a European perspective","volume":"163","author":"Guignat","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"23","key":"2026101520035944200_dgag229-B28","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.3390\/cancers13236134","article-title":"An update on silent corticotroph adenomas: diagnosis, mechanisms, clinical features, and management","volume":"13","author":"Jiang","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2026101520035944200_dgag229-B29","doi-asserted-by":"crossref","first-page":"101485","DOI":"10.1016\/j.beem.2021.101485","article-title":"The definition of remission and recurrence of Cushing's disease","volume":"35","author":"Hinojosa-Amaya","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"2026101520035944200_dgag229-B30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","article-title":"A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up","volume":"126","author":"Trouillas","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"6","key":"2026101520035944200_dgag229-B31","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1093\/ejendo\/lvaf100","article-title":"Revised European Society of Endocrinology clinical practice guideline for the management of aggressive pituitary tumours and pituitary carcinomas","volume":"192","author":"Raverot","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"14","key":"2026101520035944200_dgag229-B32","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"16","key":"2026101520035944200_dgag229-B33","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"5","key":"2026101520035944200_dgag229-B34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat Genet"},{"issue":"11","key":"2026101520035944200_dgag229-B35","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/nar\/gkx193","article-title":"NGSCheckMate: software for validating sample identity in next-generation sequencing studies within and across data types","volume":"45","author":"Lee","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2026101520035944200_dgag229-B36","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/bioinformatics\/btv566","article-title":"Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data","volume":"32","author":"Okonechnikov","year":"2016","journal-title":"Bioinformatics"},{"issue":"3","key":"2026101520035944200_dgag229-B37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"key":"2026101520035944200_dgag229-B38","doi-asserted-by":"crossref","unstructured":"Wilm A, Aw PPK, Bertrand D, et al \u00a0LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res. 2012;40(22):11189-11201.","DOI":"10.1093\/nar\/gks918"},{"issue":"13","key":"2026101520035944200_dgag229-B39","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/bioinformatics\/btaa888","article-title":"Somatic variant analysis of linked-reads sequencing data with Lancet","volume":"37","author":"Musunuri","year":"2021","journal-title":"Bioinformatics"},{"issue":"10","key":"2026101520035944200_dgag229-B40","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jvir.2010.05.021","article-title":"Percutaneous occlusion of the left subclavian and celiac arteries before or during endograft repair of thoracic and thoracoabdominal aortic aneurysms with detachable nitinol vascular plugs","volume":"21","author":"Tholpady","year":"2010","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"2026101520035944200_dgag229-B41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13029-016-0060-z","article-title":"PureCN: copy number calling and SNV classification using targeted short read sequencing","volume":"11","author":"Riester","year":"2016","journal-title":"Source Code Biol Med"},{"issue":"1","key":"2026101520035944200_dgag229-B42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-Seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"7","key":"2026101520035944200_dgag229-B43","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"2026101520035944200_dgag229-B44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"Edger: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"4","key":"2026101520035944200_dgag229-B45","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.celrep.2014.10.035","article-title":"Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes","volume":"9","author":"Biton","year":"2014","journal-title":"Cell Rep"},{"issue":"7","key":"2026101520035944200_dgag229-B46","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"2026101520035944200_dgag229-B47","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"issue":"1","key":"2026101520035944200_dgag229-B48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13059-019-1842-9","article-title":"Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods","volume":"20","author":"Haas","year":"2019","journal-title":"Genome Biol"},{"issue":"6","key":"2026101520035944200_dgag229-B49","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1093\/ejendo\/lvaf097","article-title":"Prevalence and clinical associations of USP8 variants in corticotroph tumours: a systematic review and aggregate data meta-analysis of 2171 cases","volume":"192","author":"Perez-Rivas","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"2026101520035944200_dgag229-B50","unstructured":"Paes T, Zhang Q, Borges CO, et al \u00a0Supplementary data for: Distinct genetic alterations drive Cushing disease versus silent corticotroph adenomas. 10.6084\/m9.figshare.32230560."},{"issue":"1","key":"2026101520035944200_dgag229-B51","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1210\/clinem\/dgaf269","article-title":"The USP8 mutational status in combination with postsurgical cortisol levels for predicting recurrence of Cushing disease","volume":"111","author":"Zhou","year":"2025;","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026101520035944200_dgag229-B52","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/cen.13802","article-title":"The USP8 mutational status may predict long-term remission in patients with Cushing\u2019s disease","volume":"89","author":"Albani","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2026101520035944200_dgag229-B53","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1210\/jc.2017-00161","article-title":"Somatic USP8 gene mutations are a common cause of pediatric Cushing disease","volume":"102","author":"Faucz","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026101520035944200_dgag229-B54","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S2213-8587(25)00396-1","article-title":"Risk of recurrence after successful surgery for Cushing's disease and association with USP8 genotype and tumour size: an international, retrospective, longitudinal cohort study","volume":"14","author":"Zhang","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2026101520035944200_dgag229-B55","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.3171\/2020.10.JNS203236","article-title":"Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence","volume":"135","author":"Strickland","year":"2021","journal-title":"J Neurosurg"},{"issue":"7","key":"2026101520035944200_dgag229-B56","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1210\/clinem\/dgad098","article-title":"Aggressive pituitary tumors and pituitary carcinomas: from pathology to treatment","volume":"108","author":"Burman","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026101520035944200_dgag229-B57","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1210\/clinem\/dgaa749","article-title":"Corticotroph aggressive pituitary tumors and carcinomas frequently harbor ATRX mutations","volume":"106","author":"Casar-Borota","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026101520035944200_dgag229-B58","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3389\/fonc.2018.00510","article-title":"Identification of novel genes involved in the pathogenesis of an ACTH-secreting pituitary carcinoma: a case report and literature review","volume":"8","author":"Guo","year":"2018","journal-title":"Front Oncol"},{"issue":"12","key":"2026101520035944200_dgag229-B59","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1055\/a-2337-2265","article-title":"An update on the genetic drivers of corticotroph tumorigenesis","volume":"132","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2024","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"2026101520035944200_dgag229-B60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/A:1025313214951","article-title":"Genomic instability in pituitary adenomas","volume":"5","author":"Szymas","year":"2002","journal-title":"Pituitary"},{"issue":"7","key":"2026101520035944200_dgag229-B61","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1158\/1078-0432.CCR-16-0790","article-title":"Landscape of genomic alterations in pituitary adenomas","volume":"23","author":"Bi","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2026101520035944200_dgag229-B62","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00428-022-03484-4","article-title":"Gene fusions are frequent in ACTH-secreting neuroendocrine neoplasms of the pancreas, but not in their non-pancreatic counterparts","volume":"482","author":"Agaimy","year":"2023","journal-title":"Virchows Arch"},{"issue":"6","key":"2026101520035944200_dgag229-B63","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","article-title":"Clinical biology of the pituitary adenoma","volume":"43","author":"Melmed","year":"2022","journal-title":"Endocr Rev"},{"issue":"1","key":"2026101520035944200_dgag229-B64","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0796","article-title":"European Society of Endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas","volume":"178","author":"Raverot","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026101520035944200_dgag229-B65","doi-asserted-by":"crossref","first-page":"a026062","DOI":"10.1101\/cshperspect.a026062","article-title":"Tumor-suppressor functions of the TP53 pathway","volume":"6","author":"Aubrey","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6","key":"2026101520035944200_dgag229-B66","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","article-title":"Putting p53 in context","volume":"170","author":"Kastenhuber","year":"2017","journal-title":"Cell"},{"issue":"5","key":"2026101520035944200_dgag229-B67","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/path.4321","article-title":"Effects of TP53 mutational status on gene expression patterns across 10 human cancer types","volume":"232","author":"Parikh","year":"2014","journal-title":"J Pathol"},{"issue":"9","key":"2026101520035944200_dgag229-B68","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/modpathol.2011.85","article-title":"Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis","volume":"24","author":"Yemelyanova","year":"2011","journal-title":"Mod Pathol"},{"issue":"1","key":"2026101520035944200_dgag229-B69","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13000-022-01273-w","article-title":"P53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations","volume":"17","author":"Sung","year":"2022","journal-title":"Diagn Pathol"},{"key":"2026101520035944200_dgag229-B70","first-page":"19-0046","article-title":"Postoperative expression of Cushing disease in a young male: metamorphosis of silent corticotroph adenoma?","volume":"2019","author":"Jahan","year":"2019","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"1","key":"2026101520035944200_dgag229-B71","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1472-6823-14-70","article-title":"Evolution in functionality of a metastatic pancreatic neuroendocrine tumour (pNET) causing Cushing's syndrome: treatment response with chemotherapy","volume":"14","author":"Rajeev","year":"2014","journal-title":"BMC Endocr Disord"},{"key":"2026101520035944200_dgag229-B72","doi-asserted-by":"crossref","first-page":"555963","DOI":"10.3389\/fonc.2020.555963","article-title":"Case reports: Transformation of end-stage neuroendocrine tumors with uncontrollable liver metastasis into a novel or additional functional phenotype","volume":"10","author":"Kessoku","year":"2020","journal-title":"Front Oncol"},{"key":"2026101520035944200_dgag229-B73","first-page":"150032","article-title":"Pancreatic neuroendocrine tumors with transformation to insulinoma: an unusual presentation of a rare disease","volume":"2015","author":"Nahmias","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"4","key":"2026101520035944200_dgag229-B74","first-page":"175","article-title":"Non-functioning neuroendocrine pancreatic tumors transforming to malignant insulinomas\u2014four cases and review of the literature","volume":"40","author":"Juhlin","year":"2019","journal-title":"Neuro Endocrinol Lett"},{"issue":"1","key":"2026101520035944200_dgag229-B75","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1038\/s41467-018-06498-2","article-title":"ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup","volume":"9","author":"Chan","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"2026101520035944200_dgag229-B76","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/j.gastro.2013.10.020","article-title":"Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors","volume":"146","author":"Marinoni","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"2026101520035944200_dgag229-B77","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12885-021-07978-3","article-title":"The association of sex-biased ATRX mutation in female gastric cancer patients with enhanced immunotherapy-related anticancer immunity","volume":"21","author":"Ge","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"2026101520035944200_dgag229-B78","doi-asserted-by":"crossref","first-page":"18436","DOI":"10.1038\/s41598-023-45786-w","article-title":"Novel, clinically relevant genomic patterns identified by comprehensive genomic profiling in ATRX-deficient IDH-wildtype adult high-grade gliomas","volume":"13","author":"Bedics","year":"2023","journal-title":"Sci Rep"},{"issue":"19","key":"2026101520035944200_dgag229-B79","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1182\/bloodadvances.2024012929","article-title":"Impact of cancer therapy on clonal hematopoiesis mutations and subsequent clinical outcomes","volume":"8","author":"Nead","year":"2024","journal-title":"Blood Adv"},{"issue":"3","key":"2026101520035944200_dgag229-B80","doi-asserted-by":"crossref","first-page":"e1000324","DOI":"10.1371\/journal.pbio.1000324","article-title":"Irradiation selects for p53-deficient hematopoietic progenitors","volume":"8","author":"Marusyk","year":"2010","journal-title":"PLoS Biol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag229\/68509377\/dgag229.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/11\/3062\/68509377\/dgag229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/11\/3062\/68509377\/dgag229.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:04:12Z","timestamp":1792109052000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/11\/3062\/8705629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":80,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6,11]]},"published-print":{"date-parts":[[2026,10,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag229","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,6,11]]}}}